作者
Huai Zhang,Xiaodong Zhou,Michael D. Shapiro,Gregory Y.H. Lip,Herbert Tilg,Luca Valenti,Virend K. Somers,Christopher D. Byrne,Giovanni Targher,Wah Yang,Octavio Viveiros,Christopher Opio,Christos S. Mantzoros,John Ryan,Kenneth Yuh Yen Kok,Nozim Adxamovich Jumaev,Nilanka Perera,Andrew Gerard Robertson,Adam Abu-Abeid,Anoop Misra,Yu Jun Wong,Elena Ruiz-Úcar,Oral Ospanov,Mehmet Kızılkaya,Fei Luo,Nahúm Méndez‐Sánchez,Mauricio Zuluaga,Amedeo Lonardo,Hazem Al Momani,Carlos J. Toro‐Huamanchumo,Leon A. Adams,Said A. Al‐Busafi,Ala I. Sharara,Wah‐Kheong Chan,Syed Imran Abbas,Silvia Sookoian,Sombat Treeprasertsuk,Ponsiano Ocama,Khalid Alswat,Alice P.S. Kong,Karim Ataya,Michelle Ching Lim-Loo,Rodolfo J. Oviedo,Olivia Szepietowski,Yasser Fouad,Huijie Zhang,Tamer N Abdelbaki,Christos S. Katsouras,Arun Prasad,Omar Thaher,Arshad Ali,Gabriel A Molina,Ki‐Chul Sung,Qin‐Fen Chen,Cosmas Rinaldi Adithya Lesmana,Ming‐Hua Zheng
摘要
Common metabolic diseases, such as type 2 diabetes mellitus (T2DM), hypertension, obesity, hypercholesterolemia, and metabolic dysfunction-associated steatotic liver disease (MASLD), have become a global health burden in the last three decades. The Global Burden of Disease, Injuries, and Risk Factors Study (GBD) data enables the first insights into the trends and burdens of these metabolic diseases from 1990 to 2021, highlighting regional, temporal and differences by sex.